Intralipid and blood bilirubin unconjugated increased Patient Reports February 10, 2010

Intralipid Side Effects Report #4556550-0
Intralipid side effect was reported by a Pharmacist from on Sept 17, 2004. Male patient, weighting 13.23 lb, was diagnosed with congenital intestinal malformation and was treated with Intralipid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood bilirubin unconjugated increased, liver function test abnormal. Intralipid dosage: 33 ML/ 1 DAILY/ INTRAVENOUS INF. During the same period patient was treated with DEXTROSE, TROPHAMINE, CYSTEINE, ZANTAC. Patient recovered.